Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
1 other identifier
observational
21
1 country
1
Brief Summary
Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). This study will be an exploratory analysis by miRNA expression profiling using microarrays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2011
CompletedFirst Posted
Study publicly available on registry
November 30, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedNovember 6, 2012
November 1, 2012
1 month
November 26, 2011
November 5, 2012
Conditions
Study Arms (3)
Primary Cutaneous Malignant Melanoma
Cutaneous Malignant Melanoma Metastases
Benign Melanocytic Nevi
Interventions
Biopsy
Eligibility Criteria
Patients with * Primary Cutaneous Malignant Melanoma * Cutaneous Malignant Melanoma Metastases * Benign Melanocytic Naevi
You may qualify if:
- Primary Cutaneous Malignant Melanoma
- Cutaneous Malignant Melanoma Metastases
- Benign Melanocytic Naevi
You may not qualify if:
- \- Other Skin Cancer than Primary Cutaneous Malignant Melanoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, 44791, Germany
Related Publications (1)
Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.
PMID: 23111773RESULT
Biospecimen
skin biopsy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Falk G Bechara, PD Dr.
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
- STUDY CHAIR
Peter Altmeyer, Prof. Dr.
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 26, 2011
First Posted
November 30, 2011
Study Start
December 1, 2011
Primary Completion
January 1, 2012
Last Updated
November 6, 2012
Record last verified: 2012-11